| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEVI STRAUSS & CO | Director | Class A Common Stock | 173K | $4.02M | $23.30 | Nov 4, 2025 | Direct |
| LEVI STRAUSS & CO | Director | Class B Common Stock | 14.2K | $2.2M | $17.93 | Nov 4, 2025 | Direct |
| Revance Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $3.65 | Feb 6, 2025 | Direct |
| Revance Therapeutics, Inc. | Director | Stock Option (Right to buy) | 23.5K | May 1, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LEVI | LEVI STRAUSS & CO | Nov 4, 2025 | 2 | $0 | 4 | Nov 6, 2025 | Director |
| LEVI | LEVI STRAUSS & CO | Aug 8, 2025 | 2 | $0 | 4 | Aug 12, 2025 | Director |
| LEVI | LEVI STRAUSS & CO | May 9, 2025 | 2 | $0 | 4 | May 12, 2025 | Director |
| LEVI | LEVI STRAUSS & CO | Apr 23, 2025 | 3 | $0 | 4 | Apr 25, 2025 | Director |
| LEVI | LEVI STRAUSS & CO | Feb 28, 2025 | 2 | $0 | 4 | Mar 4, 2025 | Director |
| RVNC | Revance Therapeutics, Inc. | Feb 4, 2025 | 2 | -$104K | 4 | Feb 6, 2025 | Director |
| LEVI | LEVI STRAUSS & CO | Nov 14, 2024 | 2 | $0 | 4 | Nov 18, 2024 | Director |
| LEVI | LEVI STRAUSS & CO | Aug 20, 2024 | 2 | $0 | 4 | Aug 22, 2024 | Director |
| LEVI | LEVI STRAUSS & CO | May 23, 2024 | 2 | $0 | 4 | May 28, 2024 | Director |
| RVNC | Revance Therapeutics, Inc. | May 1, 2024 | 2 | $0 | 4 | May 3, 2024 | Director |
| LEVI | LEVI STRAUSS & CO | Apr 24, 2024 | 1 | $0 | 4 | Apr 26, 2024 | Director |
| LEVI | LEVI STRAUSS & CO | Feb 23, 2024 | 2 | $0 | 4 | Feb 27, 2024 | Director |
| LEVI | LEVI STRAUSS & CO | Nov 9, 2023 | 2 | $0 | 4 | Nov 13, 2023 | Director |
| LEVI | LEVI STRAUSS & CO | Aug 17, 2023 | 2 | $0 | 4 | Aug 21, 2023 | Director |
| LEVI | LEVI STRAUSS & CO | May 18, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
| RVNC | Revance Therapeutics, Inc. | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
| LEVI | LEVI STRAUSS & CO | Apr 19, 2023 | 1 | $0 | 4 | Apr 21, 2023 | Director |
| LEVI | LEVI STRAUSS & CO | Feb 23, 2023 | 2 | $0 | 4 | Feb 27, 2023 | Director |
| LEVI | LEVI STRAUSS & CO | Nov 21, 2022 | 1 | $0 | 4 | Nov 23, 2022 | Director |
| LEVI | LEVI STRAUSS & CO | Aug 17, 2022 | 1 | $0 | 4 | Aug 18, 2022 | Director |
| LEVI | LEVI STRAUSS & CO | May 24, 2022 | 1 | $0 | 4 | May 25, 2022 | Director |
| RVNC | Revance Therapeutics, Inc. | May 4, 2022 | 1 | $0 | 4/A | May 13, 2022 | Director |
| LEVI | LEVI STRAUSS & CO | Apr 20, 2022 | 1 | $0 | 4 | Apr 22, 2022 | Director |
| LEVI | LEVI STRAUSS & CO | Feb 24, 2022 | 1 | $0 | 4 | Feb 28, 2022 | Director |
| LEVI | LEVI STRAUSS & CO | Nov 17, 2021 | 1 | $0 | 4 | Nov 18, 2021 | Director |
| LEVI | LEVI STRAUSS & CO | Aug 18, 2021 | 1 | $0 | 4 | Sep 2, 2021 | Director |
| LEVI | LEVI STRAUSS & CO | Jul 15, 2021 | 1 | $0 | 4 | Jul 19, 2021 | Director |
| LEVI | LEVI STRAUSS & CO | May 25, 2021 | 1 | $0 | 4 | May 26, 2021 | Director |
| RVNC | Revance Therapeutics, Inc. | May 5, 2021 | 2 | $0 | 4 | May 7, 2021 | Director |
| LEVI | LEVI STRAUSS & CO | Mar 25, 2019 | 4 | $0 | 4/A | Apr 21, 2023 | Director |